Object. Flow diverters (FDs) are increasingly used to treat complex intracranial aneurysms, but preclinical studies that could guide clinical applications are lacking. The authors designed a modular aneurysm model in canines to address this problem.
F low diverters are promising endovascular devices increasingly used in the treatment of large, giant, and complex intracranial aneurysms. 4, 20, 25 Preclinical studies have been published, 14, 15, 24 but currently available models cannot explore the foundations underlying how FDs can succeed or fail to safely occlude aneurysms. Ideally, clinicians would be able to recognize, before treating a patient, the relevant anatomical and aneurysmal variables that portend a low or a high likelihood of safe and effective occlusion with flow diversion.
In the present study, we sought to address the question of whether some anatomical "types" of aneurysms, subjected to characteristic hemodynamic forces, are more likely to become occluded than others. To this end, we created a modular aneurysm model and tested 3 variants of the model inspired by a categorization of clinical aneurysms based on CFD studies published by Hassan et al. 13 We have previously shown that FDs of a sufficiently low porosity can occlude straight sidewall aneurysms. 6 In the present article, we explored the following: 1) the effects of the incident angle of blood flow in a curved sidewall aneurysm model; 2) whether FDs can successfully occlude bifurcation aneurysms; and 3) whether decreasing device porosity (or increasing pore density) influenced aneurysm and branch occlusion rates in a bifurcation model.
Methods

Surgical Aneurysm Creation
Protocols for animal experimentation were approved by the institutional animal care committee in accordance Flow diverters failing to occlude experimental bifurcation or curved sidewall aneurysms: an in vivo study in canines with guidelines of the Canadian Council on Animal Care. All procedures were performed in 7-to 10-kg beagles after general anesthesia had been induced. The 3 models are illustrated in Fig. 1 , and descriptions of 2 of the models are available elsewhere. 6, 23 Briefly, in 21 animals, the left external jugular vein was used to create a vein-pouch aneurysm on the right carotid artery, and the left carotid artery was divided and anastomosed to the right carotid artery to form either a straight sidewall aneurysm or a bifurcation aneurysm. By placing a clip on the innominate artery, blood flow could be routed differentially through the aneurysm construct, allowing us to modify the direction of blood flow while keeping the arterial geometry constant. The curved sidewall aneurysm was formed by occluding the proximal right carotid artery, which is one of the branches of the bifurcation model. The 3 different constructions allow the study of the same aneurysm construct on the right carotid artery, modified to yield 3 types of aneurysms: 1) a straight sidewall model (with a branch); 2) a 90° curved sidewall model (without a branch); and 3) an end-wall bifurcation model (Fig. 1) .
Endovascular Treatment
Four days prior to stent implantation, we started the animals on an 81-mg daily course of ASA, a 150-mg loading dose of clopidogrel, and a daily 37.5-mg dose of clopidogrel thereafter. Endovascular treatment was performed 4-6 weeks after surgical aneurysm construction, through a coaxial microcatheter system introduced via a percutaneous transfemoral approach. Aneurysms were treated with 36-and 48-wire prototype FDs. Flow diverters are manufactured with a stent-in-stent construction, in which an inner flow-diverting stent mesh is coupled to an outer conventional higher-porosity stent. The nominal lengths of all devices ranged from 34 to 56 mm in a 3.5-mm vessel. In 3.5-mm linear glass tubes, the porosity, pore density, and maximum pore size for the 36-wire FDs were 72.4%, 5 pores/mm 2 , and 0.102 mm 2 (square pore shape), respectively, whereas for the 48-wire FDs, the nominal porosity, pore density, and maximum pore size were 70.3%, 8.2 pores/mm 2 , and 0.128 mm 2 (diamond pore shape), respectively. Clopidogrel therapy was discontinued 10 days after stent implantation, and ASA was continued until the animals were euthanized.
Angiography
Transfemoral angiography was performed in all animals immediately before and after stent placement, at 2 weeks postoperatively, and immediately prior to euthanasia at 3 months (n = 17) or 6 months (n = 3). One animal was killed at 2 weeks after angiography revealed complete thrombosis of the stented aneurysm construct. To prevent femoral hematomas on dual antiplatelet therapy, all punctured femoral arteries were surgically exposed via a small linear incision and ligated. Angiographic findings were scored by 2 experienced observers (T.D. and J.R.) using a system modified from Byrne et al. 4 A score of 0 indicated no change in aneurysm volume with treatment; a score of 1, residual contrast filling greater than 50% of the pretreatment aneurysm volume; a score of 2, residual contrast filling less than 50% of the pretreatment aneurysm volume; a score of 3, residual filling confined to the neck region; and a score of 4, no residual filling (complete occlusion). Angiography scores were dichotomized into incomplete occlusion (Scores 0-2) and complete or near-complete occlusion (Scores 3 and 4). The patency of arterial branches was also assessed, and stenoses, if present, were calculated using the 1 − N/D, where N = diameter at the most stenotic region and D = diameter of the distal normal artery.
Porosity and Pore Density
Stent porosity is a measure of the amount of open space available for blood to flow through the confines of the stent and is determined as follows: (1 − total metal surface area) × 100%. By itself, the measure of porosity is not sufficiently descriptive, because it does not take into account the size and number of individual spaces between struts. Two different stent designs with equivalent porosities can have widely divergent effects on blood flow due to differences in the size and number of struts. 1 Pore density is the number of metal-enclosed pores per unit surface area, and it is expressed in the number of pores/ millimeter squared. 19 Conceptually, stents with a higher pore density have shorter distances between struts, decreasing the physical distance that the unsupported neointima has to cover to completely seal an aneurysm neck. Alterations in porosity and pore density of devices can occur with device deformation.
Statistical Analysis
Comparisons between groups were made using the Kruskal-Wallis test for nonparametric data. When results were found to be significant, groups were compared in a 2 × 2 fashion using Mann-Whitney U-tests. Correlations between nonparametric data were explored with Spearman rank correlation coefficient Rho. All analyses were conducted using SPSS version 19.
Results
The angiographic and pathological results for each of the model aneurysm types are summarized in Table 1 .
The mean aneurysm length and width was 17 ± 6 mm × 8 ± 2 mm, respectively, and the mean neck diameter was 6 ± 2 mm. In all models, the diameter of the stented carotid arteries (and thus the jailed branches) varied from 3.25 to 4.0 mm.
One animal was killed after 2-week angiography showed complete thrombosis of the 36-wire FD-treated curved sidewall aneurysm construct. In the remaining animals, 3 of 5 straight sidewall aneurysms were completely occluded at 3 months compared with 0 of 5 curved sidewall and 1 of 7 end-wall bifurcation aneurysms. Endwall aneurysms that fail to occlude at 3 months showed no further occlusion at 6 months (3 of 3). Branches jailed by the FD stent (n = 16) remained patent in all cases, irrespective of anatomical configuration or type of device used. Stenoses of approximately 40% were present in 4 branches: 2 in the straight sidewall model and 2 in the end-wall bifurcation model (1 with the 36-wire and 1 with the 48-wire device). There was only 1 significant > 70%) parent vessel stenosis, at the level of the proximal end of the 48-wire device. The 3 types of aneurysms differed in terms of propensity for angiographically documented aneurysm occlusion (p = 0.010), metallic FSS porosity at the level of aneurysm ostium (p = 0.014), and final FSS neointimal coverage (p = 0.040). When treated with the same device, straight sidewall aneurysms were significantly more likely to become occluded, as seen on angiography, than curved sidewall aneurysms (p = 0.016), with more neointimal tissue coverage, as quantified at pathology (p = 0.032). Exploratory Spearman correlation studies suggest that aneurysm occlusion scores were linked to metallic porosities (Rho = 0.866; p = 0.058) in straight sidewall aneurysms. The portion of the FD covering the aneurysm ostium was more porous in curved sidewall (p = 0.016) and end-wall bifurcation aneurysms (p = 0.10) than in straight sidewall aneurysms (Fig. 2) . Straight sidewall aneurysms were also more likely to become occluded than end-wall bifurcation aneurysms (p = 0.018), with more neointimal coverage of the FSS (p = 0.030) (Fig.  3) . We found no difference in aneurysm occlusion scores (p = 1.000) or neointimal coverage (p = 0.947) between curved sidewall and end-wall bifurcation aneurysms. Use of a lower-porosity, higher-pore density device in the end-wall bifurcation model did not lead to a detectable difference in aneurysm occlusion scores (p = 0.788) or in neointimal tissue coverage (p = 0.927). For all aneurysms, there was a correlation between degree of angiographic occlusion and neointima formation on the portion of the device covering the aneurysm (Rho = 0.465, p = 0.039).
Flow-diverter deformations were frequent, with a localized expansion of the FD diameters at the level of the aneurysm or branch ostium, in all models. This expansion was associated with a characteristic, heterogeneous, metallic coverage of the aneurysm ostium. The overall metallic porosities where the device covered the aneurysm ostium varied greatly from one type of aneurysm to the other, as shown in Table 1 , despite the use of the same device. At pathological examination, occluded straight sidewall aneurysms were completely filled with organized thrombus, and the FD spanning the neck was covered with a thick neointima composed of multiple layers of a-actin-positive smooth muscle cells surrounded by collagen, covered with a monolayer of endothelial (factor VIII-positive) cells.
All angiographic failures were associated with widely patent aneurysms, sometimes with some unorganized clot inside the pouch. The distribution of stent struts forming the FSS was heterogeneous, with areas of low and high porosities. An increased concentration of stent struts, with lower porosity, was found in all straight sidewall aneurysms (5 of 5) but only in 9 of 16 curved sidewall or end-wall bifurcation aneurysms. For incompletely occluded aneurysms, the area where the struts became more concentrated, typically found at the midpoint of the aneurysm ostium, was partially covered with a neointima of variable thickness, on both inside (endoluminal) and outside (intraaneurysmal) surfaces. Other than on the struts in this concentrated midsection, the remainder of the struts covering the aneurysm neck (the higher-porosity areas) were either bare or partially covered with fibrin and red blood cells. These gaps in neointimal coverage permitted blood flow to leak out of the confines of the stent lumen into the aneurysm (or branch). When metallic coverage was denser, neointima was more likely to be present (Fig. 2) .
At microscopic pathological examination, occluded straight sidewall aneurysms were completely filled with organized thrombus and the FD spanning the neck was covered with a thick neointima composed of multiple layers of a-actin-positive smooth muscle cells surrounded by collagen, covered by a monolayer of endothelial (factor VIII-positive) cells.
Discussion
The most important finding of this in vivo work is that FDs can successfully occlude straight sidewall aneurysms, yet the same device may fail to occlude curved sidewall and end-wall bifurcation aneurysms. The second important finding of this work is that the same device, deployed into different types of aneurysms, can result in a wide range of metallic porosities covering the aneurysm neck, ranging from as high as 77% to as low as 17% porosity. This suggests that the deformation of an FD, as it adapts to the local anatomy (for example, diameter of parent vessel, degree of curvature, and size and shape of aneurysm ostium), leads to a substantial alteration in the amount of metallic coverage of the aneurysm ostium. Because the porosity of this important segment of the device dictates how much blood can flow through the confines of the FD to enter an aneurysm or branch, it has immediate potential consequences for the efficacy and safety of FDs, as measured by aneurysm or branch occlusion.
Flow diverters are currently considered for clinical situations in which alternate therapies are considered high risk or bound for failure. Flow diversion has been heralded as a new paradigm shift, where treatment efforts are directed toward reconstructing the diseased parent vessel bearing the aneurysm. [8] [9] [10] [11] 18 Here, we find that FD deployment into a parent vessel for luminal reconstruction alone is insufficiently predictive of aneurysm occlusion; the type of aneurysm must be taken into consideration. A device that effectively occludes one type of aneurysm may not necessarily work for another. 
In Vivo Results to Measure Treatment Outcomes
Clinicians typically evaluate device efficacy by verifying angiographically documented aneurysm occlusion rates; they evaluate device safety using clinical outcome measures, including device-or treatment-related strokes. When using animal models, angiographic occlusion rates can be measured as end points, but because animals do not typically experience strokes following treatment, assessment of safety in this context requires measurement of a surrogate outcome such as angiographic or pathological occlusion or stenosis of branches covered by the device. One of the strengths of the present work is the ability to measure the amount of metallic or neointimal coverage over the aneurysm or branch origins, which can only be done using an animal model. We presume that for an aneurysm to be safely, successfully, and durably treated by an FD it requires a host of biological events acting to eventually form a complete neointimal coverage of the device, with full closure of the aneurysm FSS, while maintaining sufficient holes in the neointimal coverage in the FSS covering the branch origin to maintain blood flow. This was confirmed at pathological examination, as straight sidewall aneurysms that were occluded showed complete neointimal coverage of the aneurysm FSS, whereas curved sidewall and end-wall bifurcation aneurysms that remained patent showed gaps in the neointimal FSS coverage (Figs. 2 and 3) . In the present study, branches remained patent in all cases, although branch ostia were often partially obstructed by a considerable amount of immature and organizing clot, as well as neointima.
Three preliminary animals, not treated with dual antiplatelet therapy, but with ASA alone, showed carotid artery thrombosis 2 weeks after flow diversion using the same device, a problem that was virtually solved with the addition of clopidogrel for 10 days. Although canine coagulation and platelet function certainly differ from that in humans, the fact that we have never had to use dual antiplatelet therapy for testing other endovascular devices, including balloon-expandable and self-expandable laser-cut stents, suggests that FD implantation may carry a greater risk of thrombogenic complications than other devices.
Potential Reasons Treatment Results may Depend on Aneurysm Types
There are several potential reasons why the type of FD (B) , and end-wall bifurcation aneurysms treated with a curving FD (C). Note the significantly denser metallic coverage (decreased metallic porosity) of the linear-deployed FD across the straight sidewall aneurysm, compared with curved sidewall and bifurcation aneurysms, treated with a curving FD. Neointimal coverage of the device over the straight sidewall aneurysm (A3) is more complete than that for the curved sidewall (B3) or end-wall (C3) aneurysms.
aneurysm may impact the efficacy of flow diversion. In increasing order of complexity, these include the incident angle of blood flow, mechanical deformation of the device, neointima formation on the metallic structure of the device, and branch flow that may offer an outlet to aneurysm flow in bifurcation aneurysms.
First, because the device is deployed across an acute angle, it adopts a curved orientation. The incident angle of blood flow striking the FSS is thus more likely to penetrate the confines of the device with end-wall or curved sidewall than with straight sidewall aneurysms, which leads to progressively increasing inertia-driven, as opposed to shear-driven, flow according to the radius of curvature, as was shown in previous CFD and in vitro studies. 21 Second, deformation of the device as it adapts to the local anatomy can change the local porosity of the FSS, influencing occlusion rates, as shown in Table 1 . After deployment, stent curvature leads to compression of the concave and expansion of the convex surfaces (Fig.  4) . The FSS, located on the convex surface, will have larger spaces, or pores, for blood to flow through.
3 This phenomenon may partly explain why metallic porosity was significantly greater in curved sidewall, rather than straight sidewall, aneurysms (Table 1) . Another factor contributing to the observed low metallic porosity of the straight sidewall aneurysms is the characteristic spindle deformity affecting self-expanding braided stents when they are oversized, which allows them to expand at the level of the ostium, causing the struts to concentrate at the midsection of the FSS. 6 Finally, the presence of branch flow likely contributes to maintaining aneurysm patency.
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In end-wall bifurcation aneurysms, in which the aneurysm and branch are covered by the same shared FSS, the aneurysm may fail to become occluded due to flow in the jailed branch. The effect of branch flow can perhaps be studied independently by comparing the results of the curved sidewall and the end-wall bifurcation models. In both models, the stent is deployed in a curving orientation and the directions of blood flow striking the FSS are equivalent. However, we found that elimination of flow in the branch did not improve aneurysm occlusion rates. We conclude that FD failure in these circumstances is not due to the influence of continued branch flow alone.
Can a Lower-Porosity Device Improve Aneurysm Occlusion Rates?
Use of a 48-wire instead of a 36-wire device did not lead to a demonstrable difference in aneurysm occlusion rates. Although several of the aforementioned factors may be responsible for maintaining aneurysm patency in spite of FD treatment, the differences in effective porosity and pore density of the 36-and 48-wire devices found at pathology was small. Another device with a substantially lower porosity may lead to successful aneurysm occlu- sion, but this may come at the cost of a higher risk of thrombosis of jailed branches or of the parent artery.
In Vivo Models are Necessary to Guide Clinical Applications
Computational fluid dynamic studies have provided useful principles regarding the influence of factors such as choice of device construction, incident angle of blood flow, and aneurysm size and morphology, 12, 16, 17, 21 but these remain theoretical, mathematical models. Their translation into in vivo results remains to be tested and confirmed. Individualized CFD studies based on imaging of particular patients can be performed, and the results of "implanting" virtual stents can also be obtained. 2, 5, 22 Multiple assumptions are included in these calculations, and virtual models cannot take into account fundamental in vivo phenomena such as the mechanical deformation of the device as it adapts to the local anatomy, platelet deposition, coagulation, and neointima formation. In vivo studies remain an essential and yet underused means for clinicians to gain clues about how the devices they intend to implant are likely to behave.
Limitations of the Study
The number of animals studied in this work is small, and long-term follow-up angiography beyond 3 months was not performed in most animals. Experimental aneurysms were surgical constructions, using venous pouches anastomosed to cervical carotid arteries; hence, results may differ significantly from spontaneous intracranial aneurysms. The models presented in this work remain to be validated. Unfortunately, we did not perform CFD studies of the experimental aneurysms. Canine biology certainly differs from human biology. In extrapolating findings from animal studies to human applications one should always be prudent. The FDs used in this work are prototypes, and the results obtained may not apply to other devices currently available.
Conclusions
The success or failure of flow diversion depends on the type of aneurysm being treated, with straight sidewall aneurysms significantly more prone to occlusion than curved sidewall or end-wall bifurcation aneurysms. The metallic porosity of the FSS at the level of the aneurysm ostium exhibited wide variation, depending on the type of aneurysm treated. In vivo studies in appropriate models can provide important insights into the pretreatment probability of aneurysm or branch occlusion following FD deployment. 
